Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 18 and younger than 80 years of age
- People who have focal epilepsy (a type of epilepsy that starts in one area of the brain) and are already scheduled for a 5-day hospital stay as part of a pre-surgery assessment
- People whose general thinking and reasoning abilities fall within a normal range, based on a standard test
- People who are enrolled in the French social security system
- People who have signed a consent form agreeing to take part in the study
Who may not be able to join:
- People who are pregnant or breastfeeding
- People who are not able to give their own informed consent under French law
- People who are considered vulnerable persons under French law (confirm with trial site)
- People who are in custody or detained by a court or government decision under French law
- People who are under legal guardianship
- People who, in the opinion of the trial team, are unlikely to follow the study requirements or may withdraw from the study early
- People who do not have any epileptic seizures recorded during their hospital stay
- People who have seizures so frequently that there is no period of at least 24 hours without a seizure following one seizure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Subtest of divided attention of the Test of Attentional Performance (TAP)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.